Lantern ($LTRN) Announces Filing of Seven Patent Applications Globally on Novel DNA-Damaging Agent with Anticancer… twitter.com/i/web/status/1…
Join our team and help transform the cancer drug development process, cost and timeline! lanternpharma.com/careers/ twitter.com/therealpanna/s…
In this @PharmExec podcast episode, CEO @therealpanna shares what he’s learned from the culture, and how it might h… twitter.com/i/web/status/1…
We are a biotech pharma at the intersection of Artificial Intelligence, genomics, and oncology drug development.
